KFDA to designate bioequivalence centers

The Korea Food and Drug Administration said on March 12 it plans to enact a bill to legislate the designation of new biocenters from July next year, as part of its effort to ensure the reliability of bioequivalence test results and to lift the level of bioequivalence centers to that of the advanced countries.

Under the plan, the qualified organizations should be equipped with human resources...